首页> 外文期刊>Journal of Breast Cancer >Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: Is Surgical Excision Obviated?
【24h】

Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: Is Surgical Excision Obviated?

机译:立体定向真空辅助乳房穿刺活检诊断为非典型性导管增生的残留微钙化:是否消除了手术切除?

获取原文
           

摘要

Purpose The purpose of our study was to evaluate the underestimation rate of atypical ductal hyperplasia (ADH) on vacuum-assisted breast biopsy (VABB), and to examine the correlation between residual microcalcifications and the underestimation rate of ADH. Methods A retrospective study was performed on 27 women (mean age, 49.2±9.2 years) who underwent additional excision for ADH via VABB for microcalcifications observed by using mammography. The mammographic findings, histopathologic diagnosis of all VABB and surgical specimens, and association of malignancy with residual microcalcifications were evaluated. The underestimation rate of ADH was also calculated. Results Of the 27 women with microcalcifications, nine were upgraded to ductal carcinoma in situ (DCIS); thus, the underestimation rate was 33.3% (9/27). There was no difference in age ( p =0.40) and extent of microcalcifications ( p =0.10) when comparing benign and malignant cases. Six of 17 patients (35.3%) with remaining calcifications after VABB were upgraded to DCIS, and three of 10 patients (30%) with no residual calcifications after VABB were upgraded ( p =1.00). Conclusion The underestimation rate of ADH on VABB was 33.3%. Furthermore, 30% of patients with no remaining calcifications were upgraded to DCIS. Therefore, we conclude that all ADH cases diagnosed via VABB should be excised regardless of the presence of residual microcalcifications.
机译:目的本研究的目的是评估真空辅助乳房活检(VABB)上的非典型导管增生(ADH)的低估率,并检查残留微钙化与ADH的低估率之间的相关性。方法回顾性研究27例女性(平均年龄49.2±9.2岁),她们接受了VABB额外切除ADH的乳房X线摄片术,观察到微钙化。评估了乳腺X线照片,所有VABB和手术标本的组织病理学诊断以及恶性与残余微钙化的相关性。还计算了ADH的低估率。结果在27例微钙化妇女中,有9例升级为原位导管癌。因此,低估率为33.3%(9/27)。比较良性和恶性病例的年龄(p = 0.40)和微钙化程度(p = 0.10)没有差异。在VABB后剩余钙化的17例患者中有6例(35.3%)升级为DCIS,而在VABB术后没有残留钙化的10例患者中有3例(30%)升级为PCIS(p = 1.00)。结论VABB对ADH的低估率为33.3%。此外,没有剩余钙化的患者中有30%升级为DCIS。因此,我们得出结论,无论残留微钙化的存在如何,均应切除通过VABB诊断的所有ADH病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号